clenbuterol has been researched along with Bronchitis in 11 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-one patients with chronic bronchitis and reversible airway obstruction participated in two single-blind, cross-over, placebo-controlled studies in inhaled clenbuterol - a new bronchodilator - and salbutamol." | 9.05 | A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. ( Baronti, A; Grieco, A; Vibelli, C, 1980) |
| "Twenty-one patients with chronic bronchitis and reversible airway obstruction participated in two single-blind, cross-over, placebo-controlled studies in inhaled clenbuterol - a new bronchodilator - and salbutamol." | 5.05 | A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. ( Baronti, A; Grieco, A; Vibelli, C, 1980) |
| "A new oral bronchodilator, NAB 365 (clenbuterol), at doses of 10, 20, 30 and 40 microgram, was studied in a double-blind placebo-controlled incomplete cross-over study in 10 patients suffering from chronic bronchitis who had reversible airway obstruction." | 5.04 | Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol). ( Brusasco, V; Chierichetti, S; Ramoino, R; Vibelli, C, 1978) |
| "Clenbuterol is a beta-2-sympathicomimetic, from a series of substituted phenylethanolamines, and it is characterised by good absorption and prolonged action after systemic administration." | 2.65 | Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation. ( Herzog, H; Perruchoud, A; Tschan, M, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (90.91) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Král, B | 1 |
| Jirkal, J | 1 |
| Eliás, J | 1 |
| Ilnerová, A | 1 |
| Dolezalová, K | 1 |
| Tilser, P | 1 |
| Villate Navarro, JI | 1 |
| Sobradillo Peña, V | 1 |
| Atxotegui Iraola-Goitia, V | 1 |
| Uresandi Romero, F | 1 |
| Sánchez García, J | 1 |
| Baronti, A | 2 |
| Grieco, A | 1 |
| Vibelli, C | 3 |
| Ito, M | 1 |
| Kaniwa, T | 1 |
| Horiuchi, H | 1 |
| Nonaka, T | 1 |
| Yamanaka, Y | 1 |
| Uno, H | 1 |
| Kishimoto, T | 1 |
| Kiyoki, M | 1 |
| Dorow, P | 2 |
| Cummiskey, J | 1 |
| Keelan, P | 1 |
| Gray, P | 1 |
| Cox, GA | 1 |
| Griceo, A | 1 |
| Brusasco, V | 1 |
| Chierichetti, S | 1 |
| Ramoino, R | 1 |
| Tschan, M | 1 |
| Perruchoud, A | 1 |
| Herzog, H | 1 |
| Miyata, T | 1 |
| Kai, H | 1 |
| Furusawa, K | 1 |
| Nakamura, H | 1 |
| Saito, M | 1 |
| Okano, Y | 1 |
| Takahama, K | 1 |
7 trials available for clenbuterol and Bronchitis
| Article | Year |
|---|---|
[Action of 3 beta-mimetic bronchodilators: clenbuterol, hexoprenaline, fenoterol. Comparative study].
Topics: Asthma; Bronchi; Bronchitis; Clenbuterol; Clinical Trials as Topic; Drug Evaluation; Ethanolamines; | 1980 |
A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Bronchitis; Chronic Disease; Clenbuterol; Clinical Tr | 1980 |
[Long-term studies using a beta-2-mimetic Spiropent)].
Topics: Adult; Asthma; Bronchitis; Clenbuterol; Clinical Trials as Topic; Ethanolamines; Female; Humans; Lon | 1978 |
Comparison of NAB 365 and salbutamol tablets in chronic bronchitis and asthma.
Topics: Adult; Aged; Albuterol; Asthma; Bronchitis; Chronic Disease; Clenbuterol; Clinical Trials as Topic; | 1978 |
Study of a new oral beta-adrenergic drug, clenbuterol, in patients with chronic bronchitis.
Topics: Aged; Bronchitis; Bronchodilator Agents; Chronic Disease; Clenbuterol; Clinical Trials as Topic; Dou | 1978 |
Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol).
Topics: Adult; Airway Resistance; Bronchitis; Chronic Disease; Clenbuterol; Clinical Trials as Topic; Dose-R | 1978 |
Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation.
Topics: Adult; Aerosols; Airway Resistance; Bronchitis; Clenbuterol; Clinical Trials as Topic; Dose-Response | 1979 |
4 other studies available for clenbuterol and Bronchitis
| Article | Year |
|---|---|
Spiropent in the treatment of reversible airways obstruction.
Topics: Adult; Asthma; Bronchitis; Child; Chronic Disease; Clenbuterol; Ethanolamines; Humans | 1982 |
Effect of clenbuterol on sulfur dioxide-induced acute bronchitis in guinea pigs.
Topics: Acute Disease; Animals; Bronchi; Bronchial Hyperreactivity; Bronchitis; Bronchoalveolar Lavage Fluid | 1995 |
[Mono- and combination therapy in chronic obstructive bronchitis. The effect of a mono- and combination therapy on total resistance in patients with chronic obstructive bronchitis].
Topics: Airway Resistance; Bronchitis; Chronic Disease; Clenbuterol; Drug Therapy, Combination; Ethylenediam | 1979 |
Secretomotor and mucolytic effects of mabuterol, a novel bronchodilator.
Topics: Adrenergic beta-Agonists; Animals; Bronchitis; Clenbuterol; Columbidae; Ethanolamines; Expectorants; | 1987 |